| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.deshrakshak.in | |
| Market Cap | 2.31 Cr. | |
| Enterprise Value(EV) | 6.80 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.86 | Trailing Twelve Months Ending 2022-09 |
| Price-Earning Ratio (PE) | 6.04 | Trailing Twelve Months Ending 2022-09 |
| Industry PE | 31.70 | Trailing Twelve Months Ending 2022-09 |
| Book Value / Share | 20.47 | Trailing Twelve Months Ending 2022-09 |
| Price to Book Value | 0.25 | Calculated using Price: 5.20 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.44 Cr. | 4,438,324 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The company is the oldest manufacturer of Pure Ayurvedic and Herbal Products as discovered by its Ancient Seers & Sages. The medicines are categorized into Patent & Proprietary (Classical) Medicines. The company is currently manufacturing around 400 products (Patent and Classical mix). And all these medicines are manufactured as per the prescribed norms and standards of the Indian Government. | ||
| 1 Day |
|
|
| 1 Week |
|
|
| 1 Month |
|
|
| 3 Month |
|
+4.84% |
| 6 Month |
|
+15.30% |
| 1 Year |
|
+26.83% |
| 2 Year |
|
+33.33% |
| 5 Year |
|
-23.30% |
| 10 Year |
|
-41.96% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 1.05 | 0.37 | 4.36 | 4.03 | 3.90 | 4.40 | 3.83 | 5.05 | 5.49 | |
| Return on Capital Employed (%) | 2.55 | 2.54 | 5.98 | 5.33 | 5.54 | 5.99 | 5.77 | 6.69 | 6.44 | |
| Return on Assets (%) | 0.73 | 0.26 | 2.96 | 2.78 | 2.69 | 3.01 | 2.56 | 3.12 | 3.13 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 9 | 9 | 9 | |
| Non Curr. Liab. | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 5 | |
| Curr. Liab. | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 9 | 10 | 10 | 10 | 11 | 11 | 12 | 15 | 16 | 17 | |
| Non Curr. Assets | 5 | 5 | 6 | 6 | 7 | 7 | 8 | 9 | 11 | 11 | |
| Curr. Assets | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 5 | 6 | 6 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 9 | 10 | 10 | 10 | 11 | 11 | 12 | 15 | 16 | 17 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 4 | 4 | 5 | 5 | 5 | 6 | 5 | 7 | 6 | 6 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Total Income | 4 | 4 | 5 | 5 | 5 | 6 | 5 | 7 | 6 | 6 | |
| Total Expenditure | -3 | -4 | -4 | -4 | -4 | -5 | -4 | -6 | -5 | -5 | |
| PBIDT | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Exceptional Items | |||||||||||
| PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Adjusted EPS | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | 0 | 1 | 0 | 0 | -1 | 1 | 1 | 0 | |
| Cash Fr. Inv. | 0 | 0 | 0 | -1 | -1 | 0 | 0 | -1 | -1 | -2 | |
| Cash Fr. Finan. | 0 | 1 | 1 | 1 | |||||||
| Net Change | 0 | 0 | 0 | 1 | -1 | 0 | 0 | 0 | 0 | 0 | |
| Cash & Cash Eqvt | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
|
Mon, 20 Feb 2023
Revision In Authorised Key Managerial Personnel To Determine Materiality Of An Event Or Information And Its Disclosure Under Regulation 30(5) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015: Pursuant to Regulation 30(5) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please note that there is revision in the authorized Key Managerial Personnel for determining the materiality of an event or information and for making the disclosures of material event or information to the Stock Exchange(s) and the following Key Managerial Personnel of the Company are jointly and severally authorised for the purpose of determining the materiality of an event or information and for making the disclosures of material event or information to the Stock Exchange(s):1. Tosh Kumar Jain (Managing Director) Phone: 9557847108 and Email Id: dral96@yahoo.in2. Sohini Bansal(Company Secretary) Phone: 9557847108 and Email Id: cssohinibansal@gmail.com |
|
Tue, 14 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication We hereby submit the newspaper advertisement cuttings of the Un-Audited Financial Results for the Third Quarter and Nine Months Ended on 31.12.2022 published pursuant to regulation 47(1)(b) of Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations 2015. |
|
Mon, 13 Feb 2023
Submission Of Un-Audited Financial Results For The Third Quarter And Nine Months Ended On 31.12.2022 As Per Regulation 33 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. Pursuant to Regulation 33 of SEBl (LODR) Regulations 2015 mentioned in the captioned subject we are enclosing herewith Statement of Un-Audited Financial Results for the Third Quarter and Nine Months ended on 31st December 2022 which has been approved by the Board of Directors of the Company at its Meeting held on 13th February 2023. Also please find enclosed the Limited Review Report for the Third Quarter and Nine Months ended on 31st December 2022 by our Auditors Anil Jain & Co. in respect of the above results. You are requested to take on the record and do the needful. |
|
No Scans Found |
Equities
M.F.
Sectors